Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2014 On April 29, 2014

PR Newswire

BOULDER, Colo., April 23, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the third quarter of fiscal 2014 and hold a conference call to discuss those results on Tuesday, April 29, 2014. Ron Squarer, Chief Executive Officer and Michael Carruthers, Chief Financial Officer will lead the call.

View photo

.
Array BioPharma.

 

Conference Call Information

Date:

Tuesday, April 29, 2014

Time:

9:00 a.m. eastern time

Toll-Free:

(800) 708-4540

Toll:

(847) 619-6397

Pass Code:

36946658

Webcast, including Replay and Conference Call Slides:

http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-irhome

 

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Seven Phase 3 or pivotal studies are already in progress, or are planned to begin, within the next year. These programs include the wholly-owned hematology drug, filanesib for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (Novartis). For more information on Array, please go to www.arraybiopharma.com



CONTACT:

Tricia Haugeto


Array BioPharma Inc.


(303) 386-1193


thaugeto@arraybiopharma.com

 

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

Rates

View Comments (0)